Peptide record

TPDB10282

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10282
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb
standard
No
A 24-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
VIVFVASVAAEMMQHVYCAASKKC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C114H185N29O31S4
RNDGLPTW
AV
2586.14
8.28
3
1
15
+1
-0.39
1.050
97.50
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
1615
0.62
6
Residue Composition
number
5
A
0
R
0
N
0
D
2
C
1
E
1
Q
0
G
1
H
1
I
0
L
2
K
2
M
1
F
0
P
2
S
0
T
0
W
1
Y
5
V
Amino Acid Distribution
A: 5 R: 0 N: 0 D: 0 C: 2 E: 1 Q: 1 G: 0 H: 1 I: 1 L: 0 K: 2 M: 2 F: 1 P: 0 S: 2 T: 0 W: 0 Y: 1 V: 5
Chemical Descriptors
24 reviewed residue count
C114H185N29O31S4 sequence-only estimate (linear, free termini)
2586.14 sequence-only estimate (linear, free termini)
8.28 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-0.39 sequence-only estimate (linear, free termini)
1.050 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- bacteria E. coli (MIC 6.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC
Evidence 2 Activity

Activity

MIC
Antibacterial
12.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

MIC 6.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC 12.4 ug/ml), and yeast C. albicans (MIC 24.8 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
24.8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

led P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC 12.4 ug/ml), and yeast C. albicans (MIC 24.8 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
6.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- bacteria E. coli (MIC 6.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC
Evidence 5 Activity

Activity

MIC
Antifungal
12.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

MIC 6.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC 12.4 ug/ml), and yeast C. albicans (MIC 24.8 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
24.8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

led P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC 12.4 ug/ml), and yeast C. albicans (MIC 24.8 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
6.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- bacteria E. coli (MIC 6.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC
Evidence 8 Activity

Activity

MIC
Antiparasitic
12.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 6.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC 12.4 ug/ml), and yeast C. albicans (MIC 24.8 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
24.8 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

led P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC 12.4 ug/ml), and yeast C. albicans (MIC 24.8 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
6.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram- bacteria E. coli (MIC 6.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC
Evidence 11 Activity

Activity

MIC
Antiviral
12.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 6.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC 12.4 ug/ml), and yeast C. albicans (MIC 24.8 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
24.8 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

led P. aeruginosa) (MIC 12.4 ug/ml), GRam+ bacteria S. aureus (MIC 12.4 ug/ml), and yeast C. albicans (MIC 24.8 ug/ml). Updated 7/2021